Get the Weekly Intelligence Brief — top committee picks every Sunday.
UHS · NYSE · STOCK

Universal Health Services (UHS) Stock Analysis

Healthcare Updated September 20, 2026
$176.70
52W $140.08 – $246.33
69/100
$10.70B
7.2
1.06
AI Committee Verdict
Buy
69/100
Conviction: High · 83% agreement · 6 analysts
+37.9%
-20.7%
1.83:1
High

Is UHS Bullish or Bearish?

Bullish. Innellis AI committee rates Universal Health Services (UHS) Buy with a composite score of 69/100 , based on 6 analysts with 83% agreement. Last updated September 20, 2026.

What Would Change This View

Upgrade to Strong Buy
Requires a committee score of 75.0 — +6.31 from today. Applies on the first day at or above the line; upgrades are never dampened.
Downgrade to Watch
Requires the score to fall below 55.0 — -13.69 from today. The band boundary is 60.0, but a one-step downgrade must clear a further margin first. A score oscillating around the line should not change the rating every night.

Executive Summary

The primary driver is eps growing 29.4% yoy. Most analysts agree, and no major concerns are blocking a stronger rating.

Bull & Bear Case

Bull Case
  • P/E of 6.8 is inexpensive for the broad market — Value
  • ROE of 20.8% shows genuine earnings power backing the valuation — Value
  • EPS growing 29.4% YoY — Growth
  • Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
  • MACD histogram positive -- bullish momentum — Technical
  • News sentiment is positive (+0.40 across 5 articles, 14d) — News
Bear Case
  • Both daily and weekly trends are bearish — strong multi-timeframe downtrend.
Both cases are generated from quantitative data signals, not qualitative or forward-looking judgement. They summarise what the numbers say today.
Price History (6M)

AI Investment Committee

Committee Consensus As of September 20, 2026
Overall Committee Score
69/100
Agreement
83%
Analysts
6
Conviction
High
Sector Rank
Top 0%
of 192 Healthcare peers
Value Analyst bullish
70 / 100 · Moderate confidence
Classic value case: cheap on multiples with earnings power to back it up
+ P/E of 6.8 is inexpensive for the broad market
Growth Analyst bullish
78 / 100 · High confidence
Strong, accelerating growth with consistent execution
+ EPS growing 29.4% YoY
Technical Analyst neutral
58 / 100 · High confidence
Mixed or range-bound price action
+ MACD histogram positive -- bullish momentum
Risk Analyst bullish
70 / 100 · Low confidence
Risk profile is manageable -- leverage, volatility, and event exposure all look contained
Macro Analyst bullish
65 / 100 · Low confidence
Macro backdrop is supportive of risk assets generally, and this name's beta works in its favor
News Analyst bullish
70 / 100 · Low confidence
News flow and recent filings/analyst actions are net positive
+ News sentiment is positive (+0.40 across 5 articles, 14d)
Portfolio Manager neutral
45 / 100 · High confidence
Portfolio-level factors are mixed -- worth a deliberate sizing decision, not a default-size position
+ Portfolio position concentration is currently healthy
− Sector concentration is already high (HHI 2518.64)
Open Full Terminal →

Investment Thesis Evolution

Committee score moved marginally from 68.7 to 68.7.

Comparing 2026-09-19 to 2026-09-20 (1 day apart).

Technical Analysis

RSI (14)
54.5
Neutral
MACD Histogram
0.296
Bullish Momentum
Trend Direction
Sideways
Weekly: Downtrend
Market Structure
Hh Hl
Support
$140.14
Resistance
$243.66
Bollinger %B
0.67
Inside Bands
Price vs Moving Averages
EMA 9
$176.31 Above
EMA 21
$173.89 Above
EMA 50
$169.36 Above
EMA 200
$175.63 Above

Fundamental Analysis

Valuation
100
Growth
63
Profitability
84
Financial Health
58
Cash Flow
70
Valuation
P/E Ratio 7.2×
P/B Ratio 1.40×
PEG Ratio 0.26
Dividend Yield 0.45%
52W High $246.33
52W Low $140.08
Quality & Growth
ROE 2046.2%
ROA 933.0%
Gross Margin 9068.6%
Operating Margin 1136.4%
Revenue Growth YoY
Debt / Equity 0.70
AI Fundamental Assessment
P/E ratio of 7.2 (inexpensive relative to a 15-40x range); Price-to-book of 1.4x; PEG ratio of 0.3 (under 1.0 suggests growth is undervalued relative to price); Return on equity of 20.5%; Return on assets of 9.3%; Net margin of 8.4%; Gross margin of 90.7%; Current ratio of 1.12 (tight short-term liquidity); Debt-to-equity of 0.70; Free cash flow per share is positive (13.86); Most recent quarter missed estimates by 0.6%; EPS growth accelerating (-4.4% -> +6.4% QoQ); Average YoY EPS growth of 11.8%; Analyst estimates flat over recent quarters
Get the Full UHS Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal →
Weekly Intelligence Brief
Get the committee's top-scored stocks every Sunday.
Free · No spam · Unsubscribe anytime